Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
Cancer is classified as the uncontrollable growth of mutated cells. There are different types of cancers that correlate to ...
A group of runners will set off from York this weekend in support of an Army Major, from Catterick Garrison, who has been ...
Oncopeptides AB ( ($SE:ONCO) ) has issued an update. Oncopeptides AB announced the publication of three case reports in the Journal of Cancer ...
TOMORROW, I’ll stand at the funeral of a man who changed everything. Commander Rich Sutton MBE didn’t just fly Sea King ...
In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...
In cancer patients, the health of the thymus—a key part of the body's immune system—is associated with the outcomes these ...
A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high ...
Chemo-induced myelosuppression can affect patients’ ability to do daily tasks, and management varies by patient, treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results